Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Belatacept may be a promising treatment for alopecia areata.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Researchers found four genes that could help diagnose severe alopecia areata early.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Targeting regulatory T cells may help treat age-related diseases.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Regulatory γδ T cells help protect hair follicles from alopecia areata and promote hair regrowth.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.